1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REGULUS THERAPEUTICS INC

Regulus Therapeutics Inc

XNAS: RGLS

Download real time

1.38 0.01 (0.73%)

54.00% Fall from 52W High

163.3K XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
6S
5W
0O
3T
90.5

Market Cap

Below industry Median
-2

PE TTM

Negative PE TTM
0

PEG TTM

1

Price to Book

Below industry Median
0.1

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Regulus Therapeutics Inc is on 21 Mar 2025 for the purpose of Regulus Therapeutics Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Regulus Therapeutics Inc

The latest disclosure was made by David Baltimore in Regulus Therapeutics Inc where a trade of 19,610 Common Stock done at an average price of $1.1 was reported to US exchanges on Jan. 30, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
David Baltimore Director Purchase of securities on an exchange or from another person at price $ 1.06 per share. 30 Jan 2025 19,610 22,169 (0%) 0% 1.1 20,787 Common Stock
Joseph P. Hagan Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2025 1,350,000 1,350,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.09 per share. 30 Jan 2025 50,000 260,808 (1%) 0% 1.1 54,260 Common Stock
Preston Klassen Director, President & Head of R & D Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2025 675,000 675,000 - - Stock Option (Right to Buy)
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2025 487,500 487,500 - - Stock Option (Right to Buy)
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2025 562,500 562,500 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 1.26 per share. 13 Jan 2025 11,764 210,808 (1%) 0% 1.3 14,860 Common Stock
Joseph P. Hagan Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 1.26 per share. 13 Jan 2025 115,290 222,572 (1%) 0% 1.3 145,634 Common Stock
Preston Klassen Director, President & Head of R & D Sale of securities on an exchange or to another person at price $ 1.26 per share. 13 Jan 2025 31,445 36,055 (0%) 0% 1.3 39,721 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 1.26 per share. 13 Jan 2025 5,088 49,546 (0%) 0% 1.3 6,427 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 1.26 per share. 13 Jan 2025 38,547 54,634 (0%) 0% 1.3 48,693 Common Stock
Crispina Calsada Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.26 per share. 13 Jan 2025 38,716 50,566 (0%) 0% 1.3 48,906 Common Stock
Crispina Calsada Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.26 per share. 13 Jan 2025 5,088 45,478 (0%) 0% 1.3 6,427 Common Stock
Preston Klassen Director, President & Head of R & D Grant, award, or other acquisition of securities at price $ 1.36 per share. 09 Jan 2025 37,500 37,500 (0%) 0% 1.4 51,000 Common Stock
Preston Klassen Director, President & Head of R & D Grant, award, or other acquisition of securities at price $ 1.30 per share. 09 Jan 2025 30,000 67,500 (0%) 0% 1.3 39,000 Common Stock
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 1.30 per share. 09 Jan 2025 21,000 89,282 (0%) 0% 1.3 27,300 Common Stock
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 1.36 per share. 09 Jan 2025 62,500 68,282 (0%) 0% 1.4 85,000 Common Stock
Kathryn J. Collier Director Purchase of securities on an exchange or from another person at price $ 1.82 per share. 25 Jul 2024 4,000 6,740 (0%) 0% 1.8 7,280 Common Stock
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 60,000 60,000 - - Stock Option (Right to Buy)
William H. Rastetter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 60,000 60,000 - - Stock Option (Right to Buy)
David Baltimore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 60,000 60,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 990,000 990,000 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 60,000 60,000 - - Stock Option (Right to Buy)
Preston Klassen Director, President & Head of R & D Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 528,000 528,000 - - Stock Option (Right to Buy)
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 363,000 363,000 - - Stock Option (Right to Buy)
Pascale Witz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 60,000 60,000 - - Stock Option (Right to Buy)
Hugh Rosen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 60,000 60,000 - - Stock Option (Right to Buy)
Kathryn J. Collier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 60,000 60,000 - - Stock Option (Right to Buy)
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 462,000 462,000 - - Stock Option (Right to Buy)
Alice Shih-hou Huang Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 60,000 60,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
William H. Rastetter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
David Baltimore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Pascale Witz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Hugh Rosen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Kathryn J. Collier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Alice Shih-hou Huang Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 1.60 per share. 14 Mar 2024 250,000 978,388 (4%) 1% 1.6 400,000 Common Stock
Aker Christopher Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 1.19 per share. 18 Jan 2024 5,468 10,056 (0%) 0% 1.2 6,510 Common Stock
Crispina Calsada Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.19 per share. 18 Jan 2024 5,468 5,782 (0%) 0% 1.2 6,510 Common Stock
Hagan Joseph P. Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 1.19 per share. 18 Jan 2024 14,580 57,112 (0%) 0% 1.2 17,359 Common Stock
Aker Christopher Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2024 11,250 15,524 (0%) 0% 0 Common Stock
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2024 11,250 11,250 (0%) 0% 0 Common Stock
Klassen Preston Director, President & Head of R & D Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2024 120,000 120,000 - - Stock Option (Right to Buy)
Aker Christopher Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2024 70,000 70,000 - - Stock Option (Right to Buy)
Joseph Hagan P. Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2024 30,000 71,692 (0%) 0% 0 Common Stock
Joseph Hagan P. Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2024 249,000 249,000 - - Stock Option (Right to Buy)
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2024 85,000 85,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 15,000 15,000 - - Stock Option (Right to Buy)
William H. Rastetter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 15,000 15,000 - - Stock Option (Right to Buy)
David Baltimore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 15,000 15,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 1,312,500 1,312,500 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 15,000 15,000 - - Stock Option (Right to Buy)
Preston Klassen Director, President & Head of R & D Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 225,000 225,000 - - Stock Option (Right to Buy)
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 393,750 393,750 - - Stock Option (Right to Buy)
Pascale Witz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 15,000 15,000 - - Stock Option (Right to Buy)
Hugh Rosen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 15,000 15,000 - - Stock Option (Right to Buy)
Kathryn J. Collier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 15,000 15,000 - - Stock Option (Right to Buy)
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 375,000 375,000 - - Stock Option (Right to Buy)
Alice Shih-hou Huang Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 15,000 15,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
William H. Rastetter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
David Baltimore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Pascale Witz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Hugh Rosen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Kathryn J. Collier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Alice Shih-hou Huang Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 30,000 30,000 - - Stock Option (Right to Buy)
Preston Klassen President & Head of R & D Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2023 350,000 350,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 0.90 per share. 13 Apr 2023 222,198 728,388 (3%) 1% 0.9 200,000 Common Stock
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2023 100,000 100,000 - - Stock Option (Right to Buy)
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2023 45,000 45,000 - - Stock Option (Right to Buy)
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2023 45,000 45,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 90,000 90,000 - - Stock Option (Right to Buy)
David Baltimore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 90,000 90,000 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 90,000 90,000 - - Stock Option (Right to Buy)
Pascale Witz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 90,000 90,000 - - Stock Option (Right to Buy)
Kathryn J. Collier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 90,000 90,000 - - Stock Option (Right to Buy)
Alice Shih-hou Huang Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 90,000 90,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 300,000 300,000 - - Stock Option (Right to Buy)
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 70,000 70,000 - - Stock Option (Right to Buy)
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 50,000 50,000 - - Stock Option (Right to Buy)
Denis Drygin Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 0.23 per share. 01 Mar 2022 76,686 100,000 (0%) 0% 0.2 17,638 Common Stock
Denis Drygin Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 0.23 per share. 04 Feb 2022 23,314 23,314 (0%) 0% 0.2 5,362 Common Stock
Joseph P. Hagan Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.22 per share. 12 Jan 2022 100,000 417,006 (1%) 0% 0.2 21,520 Common Stock
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2022 1,600,000 1,600,000 - - Stock Option (Right to Buy)
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2022 480,000 480,000 - - Stock Option (Right to Buy)
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2022 480,000 480,000 - - Stock Option (Right to Buy)
Denis Drygin Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2022 400,000 400,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 0.36 per share. 30 Nov 2021 2,222,222 5,061,929 (24%) 10% 0.4 800,000 Common Stock
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.89 per share. 17 May 2021 4,186 316,292 (1%) 0% 0.9 3,726 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 0.89 per share. 17 May 2021 860 41,754 (0%) 0% 0.9 765 Common Stock
Joseph P. Hagan Director, President and CEO 14 Apr 2021 7,585 0 - - Class A-2 Convertible Preferred Stock
Joseph P. Hagan Director, President and CEO 14 Apr 2021 75,850 320,478 (1%) 0% - Common Stock
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.72 per share. 16 Feb 2021 4,144 244,628 (1%) 0% 1.7 7,128 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 1.72 per share. 16 Feb 2021 828 42,614 (0%) 0% 1.7 1,424 Common Stock
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 600,000 600,000 - - Stock Option (Right to Buy)
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 180,000 180,000 - - Stock Option (Right to Buy)
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 150,000 150,000 - - Stock Option (Right to Buy)
Denis Drygin Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 120,000 120,000 - - Stock Option (Right to Buy)
Alice Shih-hou Huang Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2021 80,000 80,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.60 per share. 14 Aug 2020 4,245 222,088 (1%) 0% 0.6 2,568 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 0.61 per share. 14 Aug 2020 872 26,638 (0%) 0% 0.6 528 Common Stock
Denis Drygin Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2020 300,000 300,000 - - Stock Option (Right to Buy)
David Baltimore None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2020 23,250 23,250 - - Stock Option (Right to Buy)
Kathryn J. Collier None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2020 23,250 23,250 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.63 per share. 15 May 2020 4,426 226,333 (1%) 0% 0.6 2,774 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 0.63 per share. 15 May 2020 909 27,510 (0%) 0% 0.6 570 Common Stock
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.83 per share. 18 Feb 2020 4,324 230,759 (1%) 0% 0.8 3,591 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 0.83 per share. 18 Feb 2020 888 28,419 (0%) 0% 0.8 737 Common Stock
Stelios Papadopoulos None 03 Feb 2020 846,320 2,039,521 (9%) 4% - Common Stock
Stelios Papadopoulos None 03 Feb 2020 84,632 0 - - Class A-2 Convertible Preferred Stock
William H. Rastetter None 03 Feb 2020 225,940 390,584 (1%) 1% - Common Stock
William H. Rastetter None 03 Feb 2020 22,594 0 - - Class A-2 Convertible Preferred Stock
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2020 900,000 900,000 - - Stock Option (Right to Buy)
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2020 210,000 210,000 - - Stock Option (Right to Buy)
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2020 150,000 150,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.97 per share. 02 Jan 2020 8,345 235,083 (1%) 0% 1.0 8,067 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 0.97 per share. 02 Jan 2020 2,239 29,307 (0%) 0% 1.0 2,164 Common Stock
Anthony A. Florence Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 900,900 900,900 - - Class A-2 Convertible Preferred Stock
Anthony A. Florence Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 9,009,000 9,009,000 - - Common Stock Purchase Warrant (Right to Buy)
Peter J. Barris Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 900,900 900,900 - - Class A-2 Convertible Preferred Stock
Peter J. Barris Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 9,009,000 9,009,000 - - Common Stock Purchase Warrant (Right to Buy)
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Dec 2019 846,320 846,320 - - Common Stock Purchase Warrant (Right to Buy)
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Dec 2019 84,632 84,632 - - Class A-2 Convertible Preferred Stock
William H. Rastetter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Dec 2019 22,594 22,594 - - Class A-2 Convertible Preferred Stock
William H. Rastetter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Dec 2019 225,940 225,940 - - Common Stock Purchase Warrant (Right to Buy)
David M. Mott Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 900,900 900,900 - - Class A-2 Convertible Preferred Stock
David M. Mott Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 9,009,000 9,009,000 - - Common Stock Purchase Warrant (Right to Buy)
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Dec 2019 7,585 7,585 - - Class A-2 Convertible Preferred Stock
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Dec 2019 75,850 75,850 - - Common Stock Purchase Warrant (Right to Buy)
Sandell D Scott Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 9,009,000 9,009,000 - - Common Stock Purchase Warrant (Right to Buy)
Sandell D Scott Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 900,900 900,900 - - Class A-2 Convertible Preferred Stock
Forest Baskett Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 900,900 900,900 - - Class A-2 Convertible Preferred Stock
Forest Baskett Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 9,009,000 9,009,000 - - Common Stock Purchase Warrant (Right to Buy)
Joshua Makower Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 9,009,000 9,009,000 - - Common Stock Purchase Warrant (Right to Buy)
Joshua Makower Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 900,900 900,900 - - Class A-2 Convertible Preferred Stock
Pascale Witz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Dec 2019 6,770 6,770 - - Class A-2 Convertible Preferred Stock
Pascale Witz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Dec 2019 67,700 67,700 - - Common Stock Purchase Warrant (Right to Buy)
Ali Behbahani Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 9,009,000 9,009,000 - - Common Stock Purchase Warrant (Right to Buy)
Ali Behbahani Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 900,900 900,900 - - Class A-2 Convertible Preferred Stock
Peter Sonsini Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 9,009,000 9,009,000 - - Common Stock Purchase Warrant (Right to Buy)
Peter Sonsini Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 900,900 900,900 - - Class A-2 Convertible Preferred Stock
Carmen Chang Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 900,900 900,900 - - Class A-2 Convertible Preferred Stock
Carmen Chang Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Dec 2019 9,009,000 9,009,000 - - Common Stock Purchase Warrant (Right to Buy)
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.64 per share. 14 Nov 2019 5,838 243,428 (1%) 0% 0.6 3,736 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 0.64 per share. 14 Nov 2019 833 31,546 (0%) 0% 0.6 533 Common Stock
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 46,500 46,500 - - Stock Option (Right to Buy)
William H. Rastetter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 46,500 46,500 - - Stock Option (Right to Buy)
David Baltimore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 46,500 46,500 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 1,000,000 1,000,000 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 46,500 46,500 - - Stock Option (Right to Buy)
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 335,000 335,000 - - Stock Option (Right to Buy)
Pascale Witz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 46,500 46,500 - - Stock Option (Right to Buy)
Hugh Rosen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 46,500 46,500 - - Stock Option (Right to Buy)
Kathryn J. Collier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 46,500 46,500 - - Stock Option (Right to Buy)
Simos Simeonidis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 46,500 46,500 - - Stock Option (Right to Buy)
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 210,000 210,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.68 per share. 01 Oct 2019 8,743 249,266 (1%) 0% 0.7 5,969 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 0.68 per share. 01 Oct 2019 2,346 32,379 (0%) 0% 0.7 1,602 Common Stock
Crispina Calsada Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Aug 2019 100,000 100,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.55 per share. 15 Aug 2019 4,375 258,009 (1%) 0% 0.6 2,409 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 0.55 per share. 15 Aug 2019 899 34,725 (0%) 0% 0.6 495 Common Stock
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.31 per share. 01 Jul 2019 5,783 262,384 (1%) 0% 1.3 7,584 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 1.31 per share. 01 Jul 2019 2,225 35,624 (0%) 0% 1.3 2,918 Common Stock
Daniel R. Chevallard Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.31 per share. 01 Jul 2019 2,669 77,870 (0%) 0% 1.3 3,500 Common Stock
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2019 10,000 10,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2019 188,385 307,519 (1%) 0% 0 Common Stock
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.22 per share. 14 May 2019 39,352 268,167 (1%) 0% 1.2 47,966 Common Stock
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2019 7,500 7,500 - - Stock Option (Right to Buy)
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2019 38,512 66,259 (0%) 0% 0 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 1.41 per share. 14 May 2019 6,950 59,309 (0%) 0% 1.4 9,796 Common Stock
Daniel R. Chevallard Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2019 8,000 8,000 - - Stock Option (Right to Buy)
Anthony A. Florence Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 3,703,704 3,703,704 - - Common Stock Purchase Warrant (Right to Buy)
Anthony A. Florence Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 256,700 256,700 - - Class A-1 Convertible Preferred Stock
Anthony A. Florence Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.08 per share. 07 May 2019 1,136,704 2,052,454 (9%) 5% 1.1 1,227,640 Common Stock
Peter J. Barris Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 256,700 256,700 - - Class A-1 Convertible Preferred Stock
Peter J. Barris Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.08 per share. 07 May 2019 1,136,704 2,052,454 (9%) 5% 1.1 1,227,640 Common Stock
Peter J. Barris Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 3,703,704 3,703,704 - - Common Stock Purchase Warrant (Right to Buy)
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2019 370,370 370,370 - - Common Stock Purchase Warrant (Right to Buy)
Stelios Papadopoulos Director Grant, award, or other acquisition of securities at price $ 1.08 per share. 07 May 2019 370,370 1,189,872 (5%) 1% 1.1 400,000 Common Stock
William H. Rastetter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2019 92,889 92,889 - - Common Stock Purchase Warrant (Right to Buy)
William H. Rastetter Director Grant, award, or other acquisition of securities at price $ 1.08 per share. 07 May 2019 92,889 154,223 (0%) 0% 1.1 100,320 Common Stock
David M. Mott Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 3,703,704 3,703,704 - - Common Stock Purchase Warrant (Right to Buy)
David M. Mott Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 256,700 256,700 - - Class A-1 Convertible Preferred Stock
David M. Mott Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.08 per share. 07 May 2019 1,136,704 2,052,454 (9%) 5% 1.1 1,227,640 Common Stock
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.08 per share. 07 May 2019 33,194 64,542 (0%) 0% 1.1 35,850 Common Stock
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2019 33,194 33,194 - - Common Stock Purchase Warrant (Right to Buy)
Sandell D Scott Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 3,703,704 3,703,704 - - Common Stock Purchase Warrant (Right to Buy)
Sandell D Scott Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 256,700 256,700 - - Class A-1 Convertible Preferred Stock
Sandell D Scott Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.08 per share. 07 May 2019 1,136,704 2,052,454 (9%) 5% 1.1 1,227,640 Common Stock
Forest Baskett Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 3,703,704 3,703,704 - - Common Stock Purchase Warrant (Right to Buy)
Forest Baskett Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.08 per share. 07 May 2019 1,136,704 2,052,454 (9%) 5% 1.1 1,227,640 Common Stock
Forest Baskett Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 256,700 256,700 - - Class A-1 Convertible Preferred Stock
Joshua Makower Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.08 per share. 07 May 2019 1,136,704 2,052,454 (9%) 5% 1.1 1,227,640 Common Stock
Joshua Makower Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 256,700 256,700 - - Class A-1 Convertible Preferred Stock
Joshua Makower Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 3,703,704 3,703,704 - - Common Stock Purchase Warrant (Right to Buy)
Pascale Witz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2019 29,630 29,630 - - Common Stock Purchase Warrant (Right to Buy)
Pascale Witz Director Grant, award, or other acquisition of securities at price $ 1.08 per share. 07 May 2019 29,630 37,849 (0%) 0% 1.1 32,000 Common Stock
Ali Behbahani Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 3,703,704 3,703,704 - - Common Stock Purchase Warrant (Right to Buy)
Ali Behbahani Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 256,700 256,700 - - Class A-1 Convertible Preferred Stock
Ali Behbahani Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.08 per share. 07 May 2019 1,136,704 2,052,454 (9%) 5% 1.1 1,227,640 Common Stock
Peter Sonsini Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.08 per share. 07 May 2019 1,136,704 2,052,454 (9%) 5% 1.1 1,227,640 Common Stock
Peter Sonsini Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 3,703,704 3,703,704 - - Common Stock Purchase Warrant (Right to Buy)
Peter Sonsini Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 256,700 256,700 - - Class A-1 Convertible Preferred Stock
Carmen Chang Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 3,703,704 3,703,704 - - Common Stock Purchase Warrant (Right to Buy)
Carmen Chang Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2019 256,700 256,700 - - Class A-1 Convertible Preferred Stock
Carmen Chang Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.08 per share. 07 May 2019 1,136,704 2,052,454 (9%) 5% 1.1 1,227,640 Common Stock
Joseph P. Hagan Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.98 per share. 01 Apr 2019 5,842 31,348 (0%) 0% 1.0 5,731 Common Stock
Christopher Aker Sr. VP & General Counsel Sale of securities on an exchange or to another person at price $ 0.98 per share. 01 Apr 2019 2,710 6,287 (0%) 0% 1.0 2,659 Common Stock
Daniel R. Chevallard Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.98 per share. 01 Apr 2019 3,253 9,372 (0%) 0% 1.0 3,192 Common Stock
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.95 per share. 05 Feb 2019 65,000 84,148 (0%) 0% 1.0 61,750 Common Stock
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2019 65,000 65,000 - - Stock Option (Right to Buy)
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2019 25,000 27,747 (0%) 0% 0 Common Stock
Christopher Aker Sr. VP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2019 25,000 25,000 - - Stock Option (Right to Buy)
Daniel R. Chevallard Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2019 30,000 30,000 - - Stock Option (Right to Buy)
Daniel R. Chevallard Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.95 per share. 05 Feb 2019 30,000 34,578 (0%) 0% 1.0 28,500 Common Stock
Timothy Michael Wright Chief R & D Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2019 40,000 40,000 - - Stock Option (Right to Buy)
Timothy Michael Wright Chief R & D Officer Grant, award, or other acquisition of securities at price $ 0.95 per share. 05 Feb 2019 40,000 62,893 (0%) 0% 1.0 38,000 Common Stock
Stelios Papadopoulos None Purchase of securities on an exchange or from another person at price $ 1.09 per share. 28 Dec 2018 50,000 835,073 (9%) 0% 1.1 54,570 Common Stock
Stelios Papadopoulos None Purchase of securities on an exchange or from another person at price $ 0.95 per share. 26 Dec 2018 90,000 758,672 (8%) 1% 1.0 85,878 Common Stock
Stelios Papadopoulos None Purchase of securities on an exchange or from another person at price $ 1.04 per share. 26 Dec 2018 26,401 785,073 (8%) 0% 1.0 27,460 Common Stock
Kathryn J. Collier None Purchase of securities on an exchange or from another person at price $ 1.41 per share. 16 Nov 2018 7,100 27,596 (0%) 0% 1.4 10,011 Common Stock
Stelios Papadopoulos None Purchase of securities on an exchange or from another person at price $ 1.33 per share. 15 Nov 2018 200,000 368,672 (4%) 2% 1.3 265,080 Common Stock
Stelios Papadopoulos None Purchase of securities on an exchange or from another person at price $ 1.38 per share. 15 Nov 2018 300,000 668,672 (7%) 3% 1.4 415,470 Common Stock
Stelios Papadopoulos None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2018 20,910 168,672 (1%) 0% 0 Common Stock
Stelios Papadopoulos None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 4,583 0 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 6,250 0 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 2,500 0 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 3,051 0 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 152 0 - - Stock Option (Right to Buy)
William H. Rastetter None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 2,500 0 - - Stock Option (Right to Buy)
William H. Rastetter None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 4,583 0 - - Stock Option (Right to Buy)
William H. Rastetter None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 6,250 0 - - Stock Option (Right to Buy)
William H. Rastetter None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 2,500 0 - - Stock Option (Right to Buy)
William H. Rastetter None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 3,051 0 - - Stock Option (Right to Buy)
William H. Rastetter None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
William H. Rastetter None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2018 23,258 79,672 (0%) 0% 0 Common Stock
William H. Rastetter None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
William H. Rastetter None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 10,625 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,875 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 625 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 625 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 625 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 416 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 416 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 1,458 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 3,051 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 2,500 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 6,250 0 - - Stock Option (Right to Buy)
David Baltimore None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 4,583 0 - - Stock Option (Right to Buy)
David Baltimore None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2018 40,339 44,131 (0%) 0% 0 Common Stock
Pascale Witz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2018 15,833 19,625 (0%) 0% 0 Common Stock
Pascale Witz None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 5,000 0 - - Stock Option (Right to Buy)
Pascale Witz None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 4,583 0 - - Stock Option (Right to Buy)
Pascale Witz None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 6,250 0 - - Stock Option (Right to Buy)
Hugh Rosen None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 6,250 0 - - Stock Option (Right to Buy)
Hugh Rosen None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 4,583 0 - - Stock Option (Right to Buy)
Hugh Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2018 19,245 22,756 (0%) 0% 0 Common Stock
Hugh Rosen None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 5,912 0 - - Stock Option (Right to Buy)
Hugh Rosen None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 2,500 0 - - Stock Option (Right to Buy)
Kathryn J. Collier None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2018 16,874 20,496 (0%) 0% 0 Common Stock
Kathryn J. Collier None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 9,166 0 - - Stock Option (Right to Buy)
Kathryn J. Collier None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 3,125 0 - - Stock Option (Right to Buy)
Kathryn J. Collier None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Nov 2018 4,583 0 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 55,000 55,000 - - Stock Option (Right to Buy)
William H. Rastetter None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 55,000 55,000 - - Stock Option (Right to Buy)
David Baltimore None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 55,000 55,000 - - Stock Option (Right to Buy)
Pascale Witz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 55,000 55,000 - - Stock Option (Right to Buy)
Hugh Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 55,000 55,000 - - Stock Option (Right to Buy)
Kathryn J. Collier None Grant, award, or other acquisition of securities at price $ 0.74 per share. 01 Jun 2018 7,695 7,695 (0%) 0% 0.7 5,694 Common Stock
Kathryn J. Collier None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 55,000 55,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2018 75,000 75,000 - - Stock Option (Right to Buy)
William H. Rastetter None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2018 75,000 75,000 - - Stock Option (Right to Buy)
David Baltimore None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2018 75,000 75,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2018 725,000 725,000 - - Stock Option (Right to Buy)
Pascale Witz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2018 75,000 75,000 - - Stock Option (Right to Buy)
Daniel R. Chevallard Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2018 250,000 250,000 - - Stock Option (Right to Buy)
Hugh Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2018 75,000 75,000 - - Stock Option (Right to Buy)
Timothy Michael Wright Chief R & D Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2018 350,000 350,000 - - Stock Option (Right to Buy)
Mark Albert Deeg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2018 100,000 100,000 - - Common Stock (Right to Buy)
Kathryn J. Collier None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2018 37,500 37,500 - - Stock Option (Right to Buy)
Kathryn J. Collier None Grant, award, or other acquisition of securities at price $ 0.64 per share. 14 Apr 2018 60,234 60,234 (0%) 0% 0.6 38,550 Common Stock
Kathryn J. Collier None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2018 110,000 110,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2018 1,000,000 1,000,000 - - Stock Option (Right to Buy)
Daniel R. Chevallard Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2018 350,000 350,000 - - Stock Option (Right to Buy)
Timothy Michael Wright Chief R & D Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2018 500,000 500,000 - - Stock Option (Right to Buy)
Mark Albert Deeg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2018 175,000 175,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Grant, award, or other acquisition of securities at price $ 0.89 per share. 04 Dec 2017 96,629 1,797,306 (1%) 0% 0.9 86,000 Common Stock
William H. Rastetter None Grant, award, or other acquisition of securities at price $ 0.89 per share. 04 Dec 2017 69,662 694,387 (0%) 0% 0.9 61,999 Common Stock
David Baltimore None Grant, award, or other acquisition of securities at price $ 0.89 per share. 04 Dec 2017 60,674 60,674 (0%) 0% 0.9 54,000 Common Stock
Mark G. Foletta None Grant, award, or other acquisition of securities at price $ 0.89 per share. 04 Dec 2017 71,910 81,910 (0%) 0% 0.9 64,000 Common Stock
Pascale Witz None Grant, award, or other acquisition of securities at price $ 0.89 per share. 04 Dec 2017 60,674 60,674 (0%) 0% 0.9 54,000 Common Stock
Hugh Rosen None Grant, award, or other acquisition of securities at price $ 0.89 per share. 04 Dec 2017 56,179 56,179 (0%) 0% 0.9 49,999 Common Stock
Timothy Michael Wright Chief R & D Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Dec 2017 100,000 100,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Purchase of securities on an exchange or from another person at price $ 0.91 per share. 25 Jul 2017 1,000,000 1,770,677 (1%) 0% 0.9 910,000 Common Stock
William H. Rastetter None Purchase of securities on an exchange or from another person at price $ 0.91 per share. 25 Jul 2017 274,725 624,625 (0%) 0% 0.9 250,000 Common Stock
Joseph P. Hagan Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.91 per share. 25 Jul 2017 219,780 241,297 (0%) 0% 0.9 200,000 Common Stock
Daniel R. Chevallard Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.91 per share. 25 Jul 2017 54,945 59,415 (0%) 0% 0.9 50,000 Common Stock
Timothy Michael Wright Chief R & D Officer Purchase of securities on an exchange or from another person at price $ 0.91 per share. 25 Jul 2017 274,725 274,725 (0%) 0% 0.9 250,000 Common Stock
Mark Albert Deeg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 100,000 100,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2017 30,000 30,000 - - Stock Option (Right to Buy)
William H. Rastetter None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2017 30,000 30,000 - - Stock Option (Right to Buy)
David Baltimore None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2017 30,000 30,000 - - Common Stock (Option to Buy)
Mark G. Foletta None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2017 30,000 30,000 - - Stock Option (Right to Buy)
Pascale Witz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2017 60,000 60,000 - - Stock Option (Right to Buy)
Hugh Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2017 30,000 30,000 - - Stock Option (Right to Buy)
Daniel R. Chevallard Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2017 100,000 100,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2017 750,000 750,000 - - Stock Option (Right to Buy)
Timothy Michael Wright Chief R & D Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2017 350,000 350,000 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Purchase of securities on an exchange or from another person at price $ 1.23 per share. 21 Mar 2017 300,000 700,677 (1%) 0% 1.2 368,100 Common Stock
Stelios Papadopoulos None Purchase of securities on an exchange or from another person at price $ 1.20 per share. 21 Mar 2017 200,000 400,677 (0%) 0% 1.2 239,800 Common Stock
William H. Rastetter None Purchase of securities on an exchange or from another person at price $ 1.15 per share. 07 Mar 2017 250,000 350,000 (0%) 0% 1.2 287,500 Common Stock
Paul C. Grint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2017 410,000 410,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2017 160,000 160,000 - - Stock Option (Right to Buy)
Timothy Michael Wright Chief R & D Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2017 32,412 32,412 - - Stock Option (Right to Buy)
Paul C. Grint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2017 130,000 130,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2017 30,000 30,000 - - Stock Option (Right to Buy)
Paul C. Grint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Oct 2016 186,640 186,640 - - Stock Option (Right to Buy)
Joseph P. Hagan Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Oct 2016 59,625 59,625 - - Stock Option (Right to Buy)
Timothy Michael Wright Chief R & D Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Oct 2016 450,000 450,000 - - Stock Option (Right to Buy)
David Baltimore None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2016 36,620 36,620 - - Stock Option (Right to Buy)
Mark G. Foletta None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2016 36,620 36,620 - - Stock Option (Right to Buy)
William H. Rastetter None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2016 36,620 36,620 - - Stock Option (Right to Buy)
Douglas E. Williams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2016 36,620 36,620 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2016 36,620 36,620 - - Stock Option (Right to Buy)
Hugh Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2016 70,952 70,952 - - Stock Option (Right to Buy)
Joseph P. Hagan Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Mar 2016 10,000 10,000 - - Common Stock
Paul C. Grint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2016 265,000 265,000 - - Stock Option (Right to Buy)
Joseph P. Hagan Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2016 420,000 420,000 - - Stock Option (Right to Buy)
Paul C. Grint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2015 30,000 30,000 - - Stock Option (Right to Buy)
Mark G. Foletta None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Aug 2015 10,000 10,000 - - Common Stock
Stelios Papadopoulos None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Aug 2015 17,500 0 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Aug 2015 17,500 0 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Aug 2015 15,677 1,823 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Aug 2015 17,500 167,500 - - Common Stock
Stelios Papadopoulos None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Aug 2015 17,500 185,000 - - Common Stock
Stelios Papadopoulos None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Aug 2015 15,677 200,677 - - Common Stock
William H. Rastetter None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Jul 2015 38,765 38,765 - - Common Stock
William H. Rastetter None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Jul 2015 61,235 100,000 - - Common Stock
Paul C. Grint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2015 500,000 500,000 - - Stock Option (Right to Buy)
David Baltimore None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2015 17,500 17,500 - - Stock Option (Right to Buy)
Mark G. Foletta None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2015 17,500 17,500 - - Stock Option (Right to Buy)
William H. Rastetter None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2015 17,500 17,500 - - Stock Option (Right to Buy)
Bruce L.A. Carter None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2015 17,500 17,500 - - Stock Option (Right to Buy)
Bruce L.A. Carter None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2015 17,500 17,500 - - Stock Option (Right to Buy)
Douglas E. Williams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2015 17,500 17,500 - - Stock Option (Right to Buy)
Stelios Papadopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2015 17,500 17,500 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Apr 2015 73,929 134,358 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Apr 2015 66,071 68,287 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Apr 2015 60,000 8,287 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Apr 2015 73,929 77,634 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Apr 2015 73,929 3,705 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Apr 2015 66,071 69,776 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Apr 2015 66,071 3,705 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Apr 2015 60,000 63,705 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Apr 2015 60,000 3,705 - - Common Stock
Bruce L.A. Carter None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Apr 2015 20,000 10,000 - - Stock Option (Right to Buy)
Bruce L.A. Carter None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Apr 2015 20,000 20,000 - - Common Stock
Bruce L.A. Carter None Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Apr 2015 20,000 0 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2015 89,230 208,287 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2015 89,230 91,696 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Mar 2015 65,614 26,082 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Mar 2015 23,616 2,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2015 70 297,517 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2015 70 2,536 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Feb 2015 70 2,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2015 3,300 299,987 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2015 2,400 297,587 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2015 3,300 5,766 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Jan 2015 3,300 2,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2015 2,400 4,866 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Jan 2015 2,400 2,466 - - Common Stock
Neil Gibson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Jan 2015 71,345 8,655 - - Common Stock
Neil Gibson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Jan 2015 8,655 0 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jan 2015 85,000 363,287 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jan 2015 60,000 303,287 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jan 2015 85,000 87,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Jan 2015 72,011 15,455 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Jan 2015 12,989 2,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jan 2015 60,000 62,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Jan 2015 33,773 28,693 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Jan 2015 26,227 2,466 - - Common Stock
Stelios Papadopoulos None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Dec 2014 150,000 150,000 - - Common Stock
Stelios Papadopoulos None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Dec 2014 150,000 0 - - Stock Option (Right to Buy)
Paul Grint Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2014 50,870 50,870 - - Stock Option (Right to Buy)
Neil Gibson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2014 90,378 90,378 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2014 231,634 231,634 - - Stock Option (Right to Buy)
David Szekeres Chief Business Officer & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2014 81,101 81,101 - - Stock Option (Right to Buy)
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Nov 2014 2,500 82,500 - - Common Stock
Neil Gibson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Nov 2014 1,000 81,500 - - Common Stock
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Nov 2014 2,500 111,500 - - Stock Option (Right to Buy)
Neil Gibson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Nov 2014 1,500 80,000 - - Common Stock
B. Lynne Parshall Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Nov 2014 1,279,411 5,516,305 - - Common Stock
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Oct 2014 2,500 114,000 - - Stock Option (Right to Buy)
Neil Gibson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Oct 2014 1,100 81,400 - - Common Stock
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Oct 2014 2,500 82,500 - - Common Stock
Neil Gibson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Oct 2014 1,200 80,200 - - Common Stock
Neil Gibson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Oct 2014 200 80,000 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Oct 2014 1,400 4,571 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Oct 2014 2,005 2,566 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Oct 2014 3,505 5,971 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Oct 2014 100 2,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Oct 2014 3,505 448,287 - - Stock Option (Right to Buy)
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Oct 2014 3,300 83,300 - - Common Stock
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Oct 2014 3,300 116,500 - - Stock Option (Right to Buy)
Neil Gibson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Oct 2014 3,300 80,000 - - Common Stock
Paul Grint Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Oct 2014 40,000 40,000 - - Stock Option (Right to Buy)
Neil Gibson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Oct 2014 40,000 40,000 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Oct 2014 88,000 88,000 - - Stock Option (Right to Buy)
David Szekeres CBO and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Oct 2014 40,000 40,000 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Oct 2014 300 451,792 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Oct 2014 400 2,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Oct 2014 300 2,766 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Oct 2014 300 2,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Oct 2014 400 2,866 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Oct 2014 400 452,092 - - Stock Option (Right to Buy)
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Oct 2014 3,000 6,908,800 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Oct 2014 4,800 6,911,800 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Oct 2014 4,300 6,916,600 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Oct 2014 400 2,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Oct 2014 105 452,892 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Oct 2014 400 452,492 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Oct 2014 400 2,866 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Oct 2014 105 2,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Oct 2014 105 2,571 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Oct 2014 3,300 6,927,650 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Oct 2014 2,000 6,920,900 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Oct 2014 4,750 6,922,900 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Oct 2014 3,750 6,934,250 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Oct 2014 3,300 6,930,950 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Oct 2014 3,250 6,938,000 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2014 2,300 452,997 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Sep 2014 2,300 2,466 - - Common Stock
Kleanthis G. Xanthopoulos Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2014 2,300 4,766 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 24 Sep 2014 3,750 6,946,250 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 24 Sep 2014 2,500 6,943,750 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 24 Sep 2014 2,500 6,941,250 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Sep 2014 2,100 6,955,600 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Sep 2014 4,100 6,950,000 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Sep 2014 1,500 6,954,100 - - Common Stock
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2014 2,000 122,000 - - Stock Option (Right to Buy)
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2014 2,000 82,000 - - Common Stock
Neil Gibson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Sep 2014 2,000 80,000 - - Common Stock
Neil Gibson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Sep 2014 2,200 80,000 - - Common Stock
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2014 2,200 82,200 - - Common Stock
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2014 2,200 119,800 - - Stock Option (Right to Buy)
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Sep 2014 2,000 6,964,600 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Sep 2014 3,500 6,957,700 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Sep 2014 3,400 6,961,200 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Sep 2014 1,650 6,975,000 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Sep 2014 6,000 6,969,000 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Sep 2014 2,400 6,966,600 - - Common Stock
Kleanthis G. Xanthopoulos Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Aug 2014 3,505 455,297 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Aug 2014 3,505 3,505 - - Common Stock
Kleanthis G. Xanthopoulos Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Aug 2014 3,505 0 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Aug 2014 1,500 6,976,650 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Aug 2014 2,000 6,978,150 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Aug 2014 1,500 6,980,150 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Aug 2014 2,500 6,986,900 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Aug 2014 5,250 6,981,650 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Aug 2014 3,000 6,989,400 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Aug 2014 2,250 6,995,600 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Aug 2014 1,450 6,992,400 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Aug 2014 1,750 6,993,850 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Aug 2014 3,150 7,002,300 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Aug 2014 2,600 6,999,700 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Aug 2014 1,850 6,997,850 - - Common Stock
Kleanthis G. Xanthopoulos Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2014 3,505 458,802 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2014 3,505 3,505 - - Common Stock
Kleanthis G. Xanthopoulos Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Aug 2014 3,505 0 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Jul 2014 1,000 7,009,800 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Jul 2014 2,600 7,005,450 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Jul 2014 1,750 7,008,050 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Jul 2014 1,850 7,012,500 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Jul 2014 1,700 7,014,350 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Jul 2014 1,700 7,010,800 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Jul 2014 3,500 7,026,050 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Jul 2014 5,000 7,016,050 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Jul 2014 5,000 7,021,050 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Jul 2014 1,800 7,035,800 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Jul 2014 4,500 7,031,300 - - Common Stock
B. Lynne Parshall Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Jul 2014 1,750 7,029,550 - - Common Stock
B. Lynne Parshall Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Jul 2014 3,100 7,038,800 - - Common Stock
B. Lynne Parshall Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Jul 2014 1,200 7,037,600 - - Common Stock
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2014 2,500 82,500 - - Common Stock
Neil Gibson Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jul 2014 2,500 80,000 - - Common Stock
Neil Gibson Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2014 2,500 124,000 - - Stock Option (Right to Buy)
Kleanthis G. Xanthopoulos Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2014 3,505 3,505 - - Common Stock
Kleanthis G. Xanthopoulos Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jul 2014 3,505 0 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters